top of page
Product, Risk & Regulation
Insights on FDA regulatory frameworks, product development, remediation, and risk management in medical device environments.
Remediation Requires Leadership, Not Just Compliance
Effective remediation during regulatory scrutiny requires cross-functional leadership and prioritization, not simply procedural compliance. Having led product teams through an FDA enforcement action, I have seen firsthand how the difference between leadership-driven remediation and compliance-driven remediation determines whether a company emerges stronger or merely survives. The Compliance Trap When a company faces a warning letter, a Form 483, or other regulatory enforcemen
eric74595
Apr 22 min read
Regulatory Feedback Is a Design Input
Regulatory interactions often reshape medical device products more than market feedback does. Yet many companies treat regulatory engagement as an obstacle to be managed rather than a design input to be integrated. In my experience, the companies that treat regulatory feedback as a constraint — in the engineering sense of the word — build better products and reach the market with fewer surprises. The Regulatory Interaction as a Signal Every FDA interaction — whether a pre-sub
eric74595
Apr 22 min read
bottom of page
